These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7826392)

  • 1. Stabilization of secondary structure of Alzheimer beta-protein by aluminum(III) ions and D-Asp substitutions.
    Vyas SB; Duffy LK
    Biochem Biophys Res Commun; 1995 Jan; 206(2):718-23. PubMed ID: 7826392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of D-amino acids at Asp23 and Ser26 residues on the conformational preference of Abeta20-29 peptides.
    Shanmugam G; Polavarapu PL; Hallgas B; Majer Z
    Biochem Biophys Res Commun; 2005 Sep; 335(3):712-22. PubMed ID: 16091285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca(2+)- and Al(3+)-induced conformational transitions of amyloid fragment H-Ile-Ile-Gly-Leu-Met-NH2.
    Laczkó I; Vass E; Soós K; Varga JL; Száraz S; Hollósi M; Penke B
    Arch Biochem Biophys; 1996 Nov; 335(2):381-7. PubMed ID: 8914936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of beta-sheet structure in amyloidogenic peptides by neutralization of aspartate: a model for amyloid nucleation.
    Orpiszewski J; Benson MD
    J Mol Biol; 1999 Jun; 289(2):413-28. PubMed ID: 10366514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine inhibits amyloid formation by the beta-peptide.
    Salomon AR; Marcinowski KJ; Friedland RP; Zagorski MG
    Biochemistry; 1996 Oct; 35(42):13568-78. PubMed ID: 8885836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation.
    Soto C; Kindy MS; Baumann M; Frangione B
    Biochem Biophys Res Commun; 1996 Sep; 226(3):672-80. PubMed ID: 8831674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuated cytotoxicity but enhanced betafibril of a mutant amyloid beta-peptide with a methionine to cysteine substitution.
    Dai XL; Sun YX; Jiang ZF
    FEBS Lett; 2007 Apr; 581(7):1269-74. PubMed ID: 17349630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment.
    Tjernberg LO; Tjernberg A; Bark N; Shi Y; Ruzsicska BP; Bu Z; Thyberg J; Callaway DJ
    Biochem J; 2002 Aug; 366(Pt 1):343-51. PubMed ID: 12023906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complexes of aluminium with peptide ligands: a Fourier transform IR spectroscopic study.
    Hollósi M; Holly S; Majer Z; Laczkó I; Fasman GD
    Biopolymers; 1995 Sep; 36(3):381-9. PubMed ID: 7669921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformation and fibrillogenesis of Alzheimer A beta peptides with selected substitution of charged residues.
    Fraser PE; McLachlan DR; Surewicz WK; Mizzen CA; Snow AD; Nguyen JT; Kirschner DA
    J Mol Biol; 1994 Nov; 244(1):64-73. PubMed ID: 7966323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racemization of the amyloidal beta Asp1 residue blocks the acceleration of fibril formation caused by racemization of the Asp23 residue.
    Sakai-Kato K; Naito M; Utsunomiya-Tate N
    Biochem Biophys Res Commun; 2007 Dec; 364(3):464-9. PubMed ID: 17959152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of side-chain characteristics on stability and oligomerization state of a de novo-designed model coiled-coil: 20 amino acid substitutions in position "d".
    Tripet B; Wagschal K; Lavigne P; Mant CT; Hodges RS
    J Mol Biol; 2000 Jul; 300(2):377-402. PubMed ID: 10873472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational mapping of amyloid peptides from the putative neurotoxic 25-35 region.
    Laczkó I; Holly S; Kónya Z; Soós K; Varga JL; Hollósi M; Penke B
    Biochem Biophys Res Commun; 1994 Nov; 205(1):120-6. PubMed ID: 7999011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligopeptide-mediated acceleration of amyloid fibril formation of amyloid beta(Abeta) and alpha-synuclein fragment peptide (NAC).
    Kuroda Y; Maeda Y; Hanaoka H; Miyamoto K; Nakagawa T
    J Pept Sci; 2004 Jan; 10(1):8-17. PubMed ID: 14959887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis.
    Kirkitadze MD; Condron MM; Teplow DB
    J Mol Biol; 2001 Oct; 312(5):1103-19. PubMed ID: 11580253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of copper binding to the peptide amyloid-beta(1-16) associated with Alzheimer's disease.
    Ma QF; Hu J; Wu WH; Liu HD; Du JT; Fu Y; Wu YW; Lei P; Zhao YF; Li YM
    Biopolymers; 2006 Sep; 83(1):20-31. PubMed ID: 16615111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abeta(25-35) and its C- and/or N-blocked derivatives: copper driven structural features and neurotoxicity.
    Giuffrida ML; Grasso G; Ruvo M; Pedone C; Saporito A; Marasco D; Pignataro B; Cascio C; Copani A; Rizzarelli E
    J Neurosci Res; 2007 Feb; 85(3):623-33. PubMed ID: 17131391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrochemical and conformational consequences of copper (Cu(I) and Cu(II)) binding to beta-amyloid(1-40).
    Brzyska M; Trzesniewska K; Wieckowska A; Szczepankiewicz A; Elbaum D
    Chembiochem; 2009 Apr; 10(6):1045-55. PubMed ID: 19263448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovine colostrum nanopeptide affects amyloid beta aggregation.
    Janusz M; Woszczyna M; Lisowski M; Kubis A; Macała J; Gotszalk T; Lisowski J
    FEBS Lett; 2009 Jan; 583(1):190-6. PubMed ID: 19084010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide.
    Cerf E; Sarroukh R; Tamamizu-Kato S; Breydo L; Derclaye S; Dufrêne YF; Narayanaswami V; Goormaghtigh E; Ruysschaert JM; Raussens V
    Biochem J; 2009 Jul; 421(3):415-23. PubMed ID: 19435461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.